Fig. 1From: Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro studyChemical structure of Cisplatin (IV) prodrugs and cellular bio-reduction. a. Bio-reduction of Cisplatin (IV) prodrugs to give rise to the biologically active Cisplatin moiety and the different fatty acid ligands (R). b. Chemical structure of the two Cisplatin (IV) prodrugs; RJY6 and RJY13Back to article page